SCHEMBL14368231

SCHEMBL14368231

Cc1ccc2c(c1)CC(=O)N(CCN1CCOCC1)C2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HPGD P15428 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ PARP2 Q9UGN5 1/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HKDC1 Q2TB90 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17244438 0.79 PDE5A (0.39) ACHEKDM4ETSHRHPGDALDH1A1
SCHEMBL26750446 0.77 KDM4E (0.52) KDM4EMAPTTSHRALDH1A1CYP3A4
SCHEMBL13867995 0.76 SIGMAR1 (0.47) MAPTTSHRPOLBMEN1KMT2A
SCHEMBL14348644 0.73 SIGMAR1 (0.45) MAPTTSHRPOLBMEN1KMT2A
SCHEMBL14149496 0.72 KDM4E (0.46) KDM4EMAPTALDH1A1POLBMEN1
SCHEMBL17244439 0.72 ITGB3 (0.51) ACHEKDM4EMAPTTSHRHPGD
SCHEMBL2839028 0.72 METAP1 (0.43) ACHEKDM4EMAPTHPGDALDH1A1
SCHEMBL17244437 0.71 ITGB3 (0.45) ACHEKDM4EMAPTTSHRHPGD
SCHEMBL18765968 0.69 MAPK1 (0.48) ACHEMAPTHPGDALDH1A1PARP1
SCHEMBL2024758 0.67 PARP1 (0.50) ACHEHPGDALDH1A1L3MBTL1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265242-A1 Novel Carbapenem Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-11-15 — — US disclosed
US-20070265242-A1 Novel Carbapenem Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265242-A1 Novel Carbapenem Compound C1R, C3AR1, OXA1L ACHE 2177/4885KDM4E 298/4885MAPT 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback